from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1430/PE16

LFCtreatmentdescriptionclass of inhibitor

-0.831

Amikacinug/mL Amikacintranslation

0.207

Cap5-10ug/mL Capreomycintranslation

-1.007

Rox10-50 ug/mL Roxithromycintranslation

1.297

SM2-5 ug/mL Streptomycintranslation

1.052

Tet5-10 ug/mL Tetracyclinetranslation

-0.001

Rif0.2-5ug/mL Rifampicintranscription

0.369

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.613

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.871

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.399

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.056

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.159

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.126

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.618

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.746

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.097

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.497

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.163

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.494

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.142

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.426

KCN5-20 ug/mL Potassium cyaniderespiration

-0.488

NaN30.2-2 mM Sodium aziderespiration

-0.533

Nigericin50 uM Nigericinrespiration

0.337

TRC10-150 ug/mL Triclosanrespiration

-0.333

TRZ10-25 ug/mL Thioridazinerespiration

-1.340

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.139

menadione6-10 ug/mL Menadionerespiration

-0.338

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.037

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.105

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.421

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.780

NRP_1Non-replicating persistence stage 1dosRassociated

0.213

Amp0.2mg/mL AmpicillincellWall

0.138

Cephalexin20-100 ug/mL CephalexincellWall

0.757

Cerulenin0.32-5 ug/mL CerulenincellWall

0.899

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.014

EMB10-20 ug/mL EthambutolcellWall

0.054

Eta12-40 ug/mL EthionamidecellWall

-0.376

INH0.2-0.4 ug/mL IsoniazidcellWall

0.059

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.516

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.091

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.705

BZA0.12 mg/mL BenzamidearomaticAmides

0.705

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.376

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.046

H2O24 mM hydrogen peroxideDNAdamaging

0.012

Levo10 ug/mL LevofloxacinDNAdamaging

0.606

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.378

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.456

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.034

UVUV-irradiationDNAdamaging

-0.029

ARP41-4 ug/mL Antitubercular compound ARP4?

0.423

Antimycin12.5-50 ug/mL Antimycin A?

0.475

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.514

PA_110-50 ug/mL Antitubercular compound PA-1?

0.510

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.435

PA8240.2-2 ug/mL PA-824?

-1.116

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.201

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.102

Verapamil50 uM Verapamil?

0.316

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.299

methoxatin10-20 ug/mL Methoxatin?